Lysando adds Dr. Holger Zimmermann to its advisory board
Lysando, a leading innovator in the fight against antibiotic-resistant bacteria, announced the appointment of Dr. Holger Zimmermann to its Advisory Board. Dr. Zimmermann’s distinguished career in the pharmaceutical sector and healthcare industry brings a wealth of experience, positioning him as a key asset in Lysando’s mission to eliminate the fear of harmful bacteria worldwide. Currently […]
Buzzreach and Oncoshot announce collaboration
Buzzreach and Oncoshot, two prominent entities in the clinical trials domain, have announced an impactful collaboration to accelerate clinical trials in Japan. The former specializes in clinical trial site recruitment and retention and project management solutions, while the latter operates a cutting-edge real-time health insights exchange platform. The collaboration will extend to Oncoshot’s strategic contract research […]
Vial appoints Emma C. Moran as the new VP of Central Nervous Systems
Vial, a global tech-driven CRO providing next-generation clinical trial management services, announced the addition of Emma C. Moran to their team. Moran will be the CRO’s new VP of Central Nervous Systems (CNS), bringing with her an impressive 28-year track record in the clinical research industry. Moran’s expertise spans various domains within the pharmaceutical sector, having worked with both […]
Biocytogen Pharmaceuticals signs a License Agreement With Pheon Therapeutics
Biocytogen Pharmaceuticals (Beijing) Co., Ltd., a global biotech company focusing on the discovery of novel antibody therapeutics, yesterday announced an antibody license agreement with Pheon Therapeutics (Pheon), a leading Antibody-Drug Conjugate (ADC) specialist developing next-generation ADCs for a wide range of hard-to-treat cancers. Under the terms of the agreement, Pheon will develop and commercialize an […]
Tagworks Pharmaceuticals announces USD 65Mln in Series A Financing Round
Tagworks Pharmaceuticals BV, the pioneer of Click-to-Release chemistry designed to deliver more effective and safer systemic therapies, today announced a $65 million Series A financing led by Ysios Capital and Gilde Healthcare with participation from Novartis Venture Fund, New Enterprise Associates (NEA), and Lightstone Ventures. They join existing investors including Meneldor and Oost NL. In conjunction with the […]
Steven Pilewski joins RQM+ as Chief Operating Officer of Laboratory Services
RQM+, one of the leading MedTech service providers, yesterday announced the appointment of Steven Pilewski as Chief Operating Officer of its Laboratory Services business unit, which provides chemical characterization and reverse chemical engineering (or “deformulation”) of complex products, as well as contaminant and failure investigations for MedTech manufacturers. The business unit was founded more than 4 […]
Rxilient Biotech and Junshi Biosciences partner to develop and commercialize Toripalimab
On 28th March 2023, Rxilient Biotech (a portfolio company of Legend Capital) and Junshi Biosciences made a joint announcement that two parties will form a joint venture to develop and commercialize toripalimab in Thailand, Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, and Vietnam. Toripalimab is an anti-PD-1 monoclonal antibody independently developed by Junshi Biosciences. […]
Escient Pharmaceuticals unveils USD120 million series C financing
Escient Pharmaceuticals, a clinical-stage company advancing novel small molecule therapeutics for the potential treatment of a broad range of neurosensory-inflammatory disorders, today announced the closing of a $120 million Series C financing. The financing was co-led by NEA, Abingworth, and Forge Life Science Partners with participation from other new investors Avego, PFM Health Sciences, and […]
VISEO Acquires Scanomi powers digital transformation in APJ region
VISEO, a global IT company specializing in digital transformation services, and Scanomi, a leading Anaplan Gold partner in Asia,recently announced that they are going to join forces. The acquisition will enhance the ability of both companies to deploy larger-scale digital projects across the APJ region. Scanomi is an Anaplan Gold Partner company specializing in managing […]
Oaktree Capital Management approves new term loan for Innocoll
Innocoll Biotherapeutics plc, a specialty pharmaceutical company and portfolio business of Gurnet Point Capital, announced recently the successful refinancing of its existing term loan facility with a new $125 million term loan provided by funds managed by Oaktree Capital Management, L.P. (“Oaktree”). As per reports, the new term loan meaningfully strengthens Innocoll’s financial flexibility and […]
